These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2233914)

  • 1. Acute response to recombinant insulin-like growth factor I in a patient with Mendenhall's syndrome.
    Quin JD; Fisher BM; Paterson KR; Inoue A; Beastall GH; MacCuish AC
    N Engl J Med; 1990 Nov; 323(20):1425-6. PubMed ID: 2233914
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of recombinant insulin-like growth factor I on IGF binding proteins and the acid-labile subunit in growth hormone insensitivity syndrome.
    Walker JL; Baxter RC; Young S; Pucilowska J; Clemmons DR; Underwood LE
    Growth Regul; 1993 Mar; 3(1):109-12. PubMed ID: 7683514
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism).
    Walker JL; Ginalska-Malinowska M; Romer TE; Pucilowska JB; Underwood LE
    N Engl J Med; 1991 May; 324(21):1483-8. PubMed ID: 2023608
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment with recombinant human insulin-like growth factor I of children with growth hormone receptor deficiency (Laron syndrome). Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
    Wilton P
    Acta Paediatr Suppl; 1992 Sep; 383():137-42. PubMed ID: 1281024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human insulin-like growth factor I and treatment in diabetes].
    Koivisto VA
    Duodecim; 1994; 110(23-24):2197-201. PubMed ID: 8654239
    [No Abstract]   [Full Text] [Related]  

  • 6. Somatomedin-1 (insulin-like growth factor-I) in clinical use. Facts and potential.
    Laron Z
    Drugs; 1993 Jan; 45(1):1-8. PubMed ID: 7680980
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.
    Ranke MB
    Trends Endocrinol Metab; 2005; 16(4):190-7. PubMed ID: 15860416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rabson-Mendenhall syndrome].
    Kishimoto M; Kasuga M
    Nihon Rinsho; 2006 Sep; Suppl 3():125-8. PubMed ID: 17022515
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin-like growth factor I: physiology, metabolic effects and clinical uses.
    Froesch ER; Hussain MA; Schmid C; Zapf J
    Diabetes Metab Rev; 1996 Oct; 12(3):195-215. PubMed ID: 8959385
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic potential of rhIGF-I in diabetes and conditions of insulin resistance.
    Froesch ER; Hussain M
    J Intern Med; 1993 Dec; 234(6):561-70. PubMed ID: 8258747
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic use of insulin-like growth factor I: lessons from in vivo animal studies.
    Gluckman PD; Ambler GR
    Acta Paediatr Suppl; 1992 Sep; 383():134-6. PubMed ID: 1458009
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin-like growth factors and their binding proteins in patients with growth hormone receptor deficiency: suggestions for new diagnostic criteria. The Kabi Pharmacia Study Group on Insulin-like Growth Factor I Treatment in Growth Hormone Insensitivity Syndromes.
    Blum WF; Ranke MB; Savage MO; Hall K
    Acta Paediatr Suppl; 1992 Sep; 383():125-6. PubMed ID: 1281023
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus.
    Zenobi PD; Jaeggi-Groisman SE; Riesen WF; Røder ME; Froesch ER
    J Clin Invest; 1992 Dec; 90(6):2234-41. PubMed ID: 1469083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acanthosis nigricans, insulin-dependent diabetes, dysmorphism: Mendenhall's syndrome?].
    Prigent F; Guillon JL; Lagardère B; Gallet JP; Duprey J
    Ann Dermatol Venereol; 1985; 112(9):755-6. PubMed ID: 4091429
    [No Abstract]   [Full Text] [Related]  

  • 15. Does recombinant human insulin-like growth factor-1 have a role in the treatment of diabetes?
    Dunger DB; Acerini CL
    Diabet Med; 1997 Sep; 14(9):723-31. PubMed ID: 9300221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies on the prevention of insulin-dependent diabetes mellitus by immunomodulation: lessons from NOD mice treated with beta-1,6;1,3-D-glucan and rhIGF-I.
    Kida K; Kaino Y; Ito T; Hirai H
    J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():327-33. PubMed ID: 9642663
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant IGF-I therapy in insulin-dependent diabetes mellitus.
    Savage MO; Dunger DB
    Diabetes Metab; 1996 Jul; 22(4):257-60. PubMed ID: 8767172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth restoration of insulin-deficient diabetic rats by recombinant human insulin-like growth factor I.
    Scheiwiller E; Guler HP; Merryweather J; Scandella C; Maerki W; Zapf J; Froesch ER
    Nature; 1986 Sep 11-17; 323(6084):169-71. PubMed ID: 3528867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acute administration of insulin-like growth factor I in patients with Laron-type dwarfism.
    Laron Z; Klinger B; Erster B; Anin S
    Lancet; 1988 Nov; 2(8621):1170-2. PubMed ID: 2903379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic effects of insulin-like growth factor I with special reference to diabetes.
    Froesch ER; Hussain M
    Acta Paediatr Suppl; 1994 Apr; 399():165-70. PubMed ID: 7949607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.